MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript May 11, 2024 MaxCyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter 2024 Earnings Conference Call. At […]
Discover how MaxCyte Inc (MXCT) achieved significant revenue increases and strategic advancements in the first quarter of 2024.